Table 6.
Comparison of features between non-stroke AF patients with higher and lower MMSE scores.
| MMSE score of ≥26n = 67 | MMSE score of <26n = 63 | P value | |
|---|---|---|---|
| Age, years | 64.9 ± 10.6 | 76.3 ± 9.5 | <0.001* |
| Education, years | 10.7 ± 4.0 | 7.0 ± 4.0 | <0.001* |
| Male sex | 45 (0.67) | 39 (0.62) | 0.584 |
| Smoking history | 17 (0.25) | 27 (0.43) | 0.045* |
| Alcohol abuse | 12 (0.18) | 20 (0.32) | 0.102 |
| Heart rate, bpm | 81.7 ± 18.1 | 82.8 ± 19.9 | 0.723 |
| Systolic blood pressure, mmHg | 131.3 ± 16.7 | 131.8 ± 17.7 | 0.854 |
| Diastolic blood pressure, mmHg | 83.0 ± 9.5 | 79.4 ± 7.6 | 0.021* |
| Coronary heart disease | 15 (0.22) | 22 (0.34) | 0.124 |
| Diabetes | 16 (0.24) | 19 (0.30) | 0.271 |
| Hypertension | 40 (0.60) | 47 (0.74) | 0.093 |
| Thyroid disease | 8 (0.13) | 11 (0.17) | 0.261 |
| Radiofrequency ablation | 13 (0.19) | 5 (0.08) | 0.076 |
| Antiplatelet therapy | 27 (0.40) | 31 (0.49) | 0.378 |
| Anticoagulation | 36 (0.54) | 21 (0.33) | 0.022* |
| ACEI/ARB | 30 (0.45) | 32 (0.51) | 0.598 |
| Statins | 20 (0.30) | 23 (0.37) | 0.495 |
| β-blocker | 30 (0.45) | 28 (0.44) | 0.970 |
| Hemoglobin g/L | 130.8 ± 19.5 | 123.5 ± 21.6 | 0.044* |
| Platelets, 1012/L | 191.1 ± 63.6 | 187.3 ± 63.9 | 0.739 |
| White blood cells, 109/L | 6.5 ± 2.5 | 6.9 ± 2.5 | 0.389 |
| Troponin T, ng/mL | 0.02 ± 0.03 | 0.04 ± 0.11 | 0.548 |
| Albumin, g/L | 37.7 ± 4.6 | 37.2 ± 5.0 | 0.854 |
| Urine protein | 11 (0.16) | 15 (0.24) | 0.518 |
| NT-proB-type natriuretic peptide, pg/mL | 992.3 ± 1517.2 | 2292.9 ± 3330.8 | 0.016* |
| Low-density lipoprotein, mmol/L | 2.0 ± 1.2 | 2.1 ± 1.2 | 0.366 |
| Serum creatinine, µmol/L | 86.5 ± 56.5 | 88.3 ± 37.0 | 0.839 |
| Uric acid, µmol/L | 336.6 ± 113.8 | 350.7 ± 121.8 | 0.494 |
| Neutrophil-to-lymphocyte ratio, % | 2.9 ± 1.8 | 4.0 ± 4.1 | 0.265 |
Data are presented as mean ± standard deviation or n (%).
*P<0.05
MMSE, Mini-Mental State Examination; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.